Larissa Doughty

发表

Fragment Screening for the Modelling Community: SPR, ITC, and Crystallography

Thomas S. Peat, Olan Dolezal, Janet Newman, 2013 .

Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1

M. Foley, R. Anders, P. Hudson, 2004, Proteins.

Dimerisation strategies for shark IgNAR single domain antibody fragments.

V. Streltsov, S. Nuttall, U. Krishnan, 2006, Journal of immunological methods.

Noncovalent scFv multimers of tumor‐targeting anti‐Lewisy hu3S193 humanized antibody

A. Scott, Zhanqi Liu, A. Kortt, 2003, Protein science : a publication of the Protein Society.

Structural Model for the Interaction of a Designed Ankyrin Repeat Protein with the Human Epidermal Growth Factor Receptor 2

Olan Dolezal, Andreas Plückthun, Christian Jost, 2013, PloS one.

Humoral Immune Response to Primary Rubella Virus Infection

K. Wilson, Larissa Doughty, Carlie Di Camillo, 2006, Clinical and Vaccine Immunology.

Cancer-targeting Antibody–Drug Conjugates: Site-specific Conjugation of Doxorubicin to Anti-EGFR 528 Fab' through a Polyethylene Glycol Linker

G. Coia, Charlotte C Williams, Larissa Doughty, 2011 .

Determinants of oligosaccharide specificity of the carbohydrate-binding modules of AMP-activated protein kinase.

M. Parker, D. Stapleton, M. Gorman, 2015, The Biochemical journal.

Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations

B. Branson, B. Kemp, K. Wilson, 2004, AIDS.

Isolation and characterization of an IgNAR variable domain specific for the human mitochondrial translocase receptor Tom70.

P. Hudson, M. Ryan, S. Nuttall, 2003, European journal of biochemistry.

Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies

J. Werkmeister, K. Ow, P. Russell, 2004, Cancer Immunology, Immunotherapy.

Structures of the interleukin 11 signalling complex reveal dynamics of gp130 extracellular domains and the inhibitory mechanism of a cytokine variant

C. Morton, E. Hanssen, P. Gooley, 2022, bioRxiv.

Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA

Jerome Wielens, David B. Ascher, Michael W. Parker, 2014, Scientific Reports.

Drugging MYCN oncogenic signalling through the MYCN-PA2G4 binding interface.

M. Fischer, A. Oberthuer, M. Parker, 2019, Cancer research.

Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis

T. Nero, M. Parker, M. Rives, 2019, iScience.

Manipulating the Lewis antigen specificity of the cholesterol-dependent cytolysin lectinolysin

M. Parker, S. Feil, J. Holien, 2012, Front. Immun..

Flow cytometric enumeration of micronucleated reticulocytes: High transferability among 14 laboratories

M. Fenech, P. Harbach, K. Sandelin, 2001, Environmental and molecular mutagenesis.

Single-chain Fv multimers of the anti-neuraminidase antibody NC10: the residue at position 15 in the V(L) domain of the scFv-0 (V(L)-V(H)) molecule is primarily responsible for formation of a tetramer-trimer equilibrium.

Olan Dolezal, Mark Walter, A. Kortt, 2003, Protein engineering.

ERRATUM: Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation

M. Parker, Luke A Miles, G. Crespi, 2013, Scientific Reports.

Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation

M. Parker, Luke A Miles, G. Crespi, 2013, Scientific Reports.

A naturally occurring NAR variable domain binds the Kgp protease from Porphyromonas gingivalis

A. Kortt, P. Hudson, S. Nuttall, 2002, FEBS letters.

ERRATUM: Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation

M. Parker, Luke A Miles, G. Crespi, 2013, Scientific Reports.

Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody

K. Ow, P. Russell, A. Kortt, 2004, Cancer Immunology, Immunotherapy.